BostonGene to Showcase Multi-Modal AI-Powered Platform at the 22nd Annual Meeting of the Japanese Society of Medical Oncology
Advancing Precision Oncology with AI-Driven Multiomics for Optimized Therapy Selection and Improved…
Predictive Oncology Closes Registered Direct Offering
February 19, 2025 17:20 ET | Source: Predictive Oncology Inc. PITTSBURGH, Feb.…
Olema Oncology to Present at the TD Cowen 45th Annual Health Care Conference
February 19, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, Feb.…
Merus to Present at Citi’s 2025 Virtual Oncology Leadership Summit
UTRECHT, The Netherlands and CAMBRIDGE, Mass., Feb. 13, 2025 (GLOBE NEWSWIRE) --…
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 04, 2025 16:30 ET | Source: Olema Oncology SAN FRANCISCO, Feb.…
Seeking Investors: First-in-Class Immunotherapeutics for Cancer
ATLANTA, Jan. 27, 2025 /PRNewswire/ -- Cambium Oncology is pleased to share…
Pfizers BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial…
Pfizers BRAFTOVI Combination Regimen Demonstrates Improved Response in Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer
Clinically meaningful and statistically significant results from the Phase 3 BREAKWATER trial…
Bristol Myers Squibb Presents Results from CheckMate -8HW Analysis Evaluating Opdivo (nivolumab) plus Yervoy (ipilimumab) Compared to Opdivo Monotherapy…
Patients experienced a 38% reduction in the risk of disease progression or…
JelloX Aims to Improve Patient-Centered Care with AI-powered 3D Digital Pathology
First shared at a recent Japanese Society of Digital Pathology meeting, the…